Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Valiant

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.
The Journal of Antibiotics|August 1, 1988
L-656,575 (OCP-9-176): a novel oxacephem. In vitro activity against aerobic and anaerobic clinical bacterial isolatesB Weissberger, G K Abruzzo, R A Fromtling, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptidesA A Patchett, D Taub, B Weissberger, et al.
The Journal of Antibiotics|November 1, 1989
L-681,572--a new antifungal agent. Isolation, characterization, and biological activityL Chaiet, R A Fromtling, G M Garrity, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial propertiesB A Weissberger, G K Abruzzo, R A Fromtling, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.
The Journal of Antibiotics|August 1, 1988
L-656,575 (OCP-9-176): a novel oxacephem. In vitro activity against aerobic and anaerobic clinical bacterial isolatesB Weissberger, G K Abruzzo, R A Fromtling, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptidesA A Patchett, D Taub, B Weissberger, et al.
The Journal of Antibiotics|November 1, 1989
L-681,572--a new antifungal agent. Isolation, characterization, and biological activityL Chaiet, R A Fromtling, G M Garrity, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial propertiesB A Weissberger, G K Abruzzo, R A Fromtling, et al.
Pageof 2